Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011)

Farhad Zamani 1 , Masoudreza Sohrabi 1 , * , Hossein Poustchi 2 , Hossein Keyvani 3 , Fatemeh Sima Saeedian 1 , Hossein Ajdarkosh 1 , Mahood Khoonsari 1 , Gholamreza Hemmasi 1 , Maziar Moradilakeh 1 , Nima Motamed 1 and Masoumeh Maadi 1
Authors Information
1 Gastrointestinal and Liver Diseases Research Center (GILDRC), Iran University of Medical Sciences, Tehran, IR Iran
2 Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran,IR Iran
3 Department of Virology, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: December 2013, 13 (12); e13313
  • Published Online: December 7, 2013
  • Article Type: Research Article
  • Received: July 1, 2013
  • Revised: August 14, 2013
  • Accepted: October 21, 2013
  • DOI: 10.5812/hepatmon.13313

To Cite: Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian F S, et al. Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011), Hepat Mon. 2013 ;13(12):e13313. doi: 10.5812/hepatmon.13313.

Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Fallahian F, Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl. 2011; 22(1): 1-9[PubMed]
  • 2. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009; 29 Suppl 1: 74-81[DOI][PubMed]
  • 3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 4. European Association for the Study of the Liver . EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011; 55(2): 245-64[DOI][PubMed]
  • 5. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31 Suppl 2: 61-80[DOI][PubMed]
  • 6. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005; 45(12): 1973-80[DOI][PubMed]
  • 7. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Sci World J. 2012; 2012: 719494[DOI][PubMed]
  • 8. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48(1): 148-62[DOI][PubMed]
  • 9. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007; 10(24): 4461-6[PubMed]
  • 10. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17(6): 425-33[DOI][PubMed]
  • 11. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013; 13(3)[DOI][PubMed]
  • 12. Makhlough A, Jamshidi M, Mahdavi MR. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran. Singapore Med J. 2008; 49(11): 921-3[PubMed]
  • 13. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 14. Poorolajal J, Mirzaei M, Bathaei SJ, Majzoobi MM. Hepatitis B and C Infections in Hamadan Province during 2004-2009. J Res Health Sci. 2011; 11(1): 51-7[PubMed]
  • 15. Ebadi M, Yaghobi R, Geramizadeh B, Bahmani MK, Malek-Hosseini SA, Nemayandeh M. Prevalence of HCV and HGV infections in Iranian liver transplant recipients. Transplant Proc. 2011; 43(2): 618-20[DOI][PubMed]
  • 16. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010; 14(3): 253-62[DOI][PubMed]
  • 17. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader